Our study indicated that the methylation ratio of RASSF1A in ACC was lower than in many other tumors, such as the primary lung cancer (88%) [30], breast carcinoma (65%–95%) [31], [32], [33] and colorectal carcinoma(52%) [21]. This evidence concerns the gene RASSF1 and colorectal carcinoma.